课题基金 / 基金详情

Oxford Impedance Diagnostics - operationalising a disruptive Point of Care platform

Oxford Impedance Diagnostics - operationalising a disruptive Point of Care platform
Oxford Impedance Diagnostics - 运营颠覆性的护理点平台
批准号:
133352
负责人:
金额:
$13.27万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们正在开发一种点护理(POC)诊断设备,它可以执行传统实验室所做的大部分测试,但它是一个可以放在全科医生办公桌上的手持设备。该设备不仅体积小,而且便宜、准确、全面(因为它可以测试各种条件)。有了这样的设备,医生可以对患者进行现场诊断,而不是将样本送到实验室,从而大大降低了整个NHS的诊断测试成本,并通过早期诊断显着改善了患者的治疗效果和健康状况。我们公司基于牛津大学的研究开发了这种设备。我们已经在我们的研究实验室证明了这个设备的原理,包括针对胰岛素、寨卡病毒、心脏标志物CRP和肌钙蛋白等关键标志物。我们现在正在对这项技术进行操作,最终目标是生产商业产品。
英文摘要
We are developing a point of care (POC) diagnostic device that can perform most of the tests a conventional laboratory does, but in a hand held device that can sit on a GPs desk. Not only small, the device will also be cheap, accurate, and comprehensive (as it can test for a huge range of conditions). With such a device, doctors could diagnose patients live, rather than sending off a sample to a lab, dramatically reducing the cost of diagnostic testing across the NHS, and significantly improving patient outcomes and health through earlier diagnosis. Our company has been developing this device based off of research from the University of Oxford. We have already proven the principle of this device in our research laboratory, including against key markers like insulin, Zika, and cardiac markers CRP and Troponin. We are now operationalising the technology, with the ultimate goal of producing a commercial product.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金